American Society for Transplantation and Cellular Therapy

American Society for Transplantation and Cellular Therapy
Name	American Society for Transplantation and Cellular Therapy
Abbreviation	AS TCT
Founded	1970s
Type	Professional association
Headquarters	United States
Region served	International
Membership	Clinicians, scientists, allied health professionals

Contents

American Society for Transplantation and Cellular Therapy is a professional organization focused on hematopoietic cell transplantation and cellular therapy, bringing together clinicians, researchers, and allied health professionals. It serves as a nexus for specialists from institutions such as Mayo Clinic, MD Anderson Cancer Center, Dana-Farber Cancer Institute, Fred Hutchinson Cancer Center, and Johns Hopkins Hospital, while engaging with regulatory and research bodies like Food and Drug Administration, National Institutes of Health, and European Society for Blood and Marrow Transplantation. The society interfaces with professional and patient organizations including American Society of Clinical Oncology, American Association of Blood Banks, Leukemia & Lymphoma Society, and National Marrow Donor Program.

History

The society traces roots to early cooperative transplant efforts contemporaneous with programs at University of Minnesota, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, and Stanford University Medical Center. Early leaders included clinicians affiliated with Memorial Sloan Kettering Cancer Center, Brigham and Women's Hospital, Cleveland Clinic, and University of Pennsylvania Health System, promoting standards adopted by bodies such as World Health Organization committees and influencing research funded by National Cancer Institute and American Cancer Society. Over decades it evolved alongside milestones at Boston Children's Hospital, M.D. Anderson Cancer Center, and international collaborations with Royal Marsden Hospital and Karolinska Institutet.

The society's mission aligns with ideals espoused by organizations like World Health Organization, Centers for Disease Control and Prevention, and Bill & Melinda Gates Foundation for advancing patient care and research. Objectives include improving outcomes at centers such as Children's Hospital of Philadelphia, Seattle Children's Hospital, and Great Ormond Street Hospital, fostering collaboration with associations like European Medicines Agency, American Red Cross, and United Nations-related health initiatives. It emphasizes evidence-based practice reflected in guidelines from National Comprehensive Cancer Network, Institute of Medicine, and policy dialogues with U.S. Congress committees on health.

Membership draws professionals from University of California, San Francisco Medical Center, Yale New Haven Hospital, Hospital of the University of Pennsylvania, and international institutions including Royal Victoria Hospital (Montreal), Hopital Saint-Louis (Paris), and University of Tokyo Hospital. Governance structures mirror models used by American Medical Association, Royal College of Physicians, and Association of American Medical Colleges, with elected officers, committees, and special interest groups representing transplant physicians, nurse coordinators, pharmacists from American Society of Health-System Pharmacists, and laboratory scientists from American Association for Clinical Chemistry.

Educational programs parallel curricula from Royal College of Physicians and Surgeons of Canada, American Board of Internal Medicine, and fellowship tracks at University of California, San Diego School of Medicine. Training initiatives include multidisciplinary modules for transplant coordinators, pharmacists from Pharmacy Practice Residency programs, and laboratory certification influenced by standards of College of American Pathologists and Clinical Laboratory Improvement Amendments. The society provides mentorship linking trainees to leaders at Memorial Sloan Kettering Cancer Center, St. Jude Children's Research Hospital, and Mayo Clinic School of Medicine.

Research priorities align with trials conducted at National Institutes of Health Clinical Center, cooperative groups such as Children's Oncology Group, and pharmaceutical collaborations with companies involved in cellular therapies. The society issues guidelines referenced alongside documents from National Comprehensive Cancer Network, European Society for Medical Oncology, and American Society of Hematology. Its publications and abstracts appear in journals and proceedings connected with New England Journal of Medicine, The Lancet, Blood (journal), and conference reports that inform policy at Food and Drug Administration and reimbursement by Centers for Medicare & Medicaid Services.

Advocacy engages lawmakers and agencies including U.S. Department of Health and Human Services, U.S. Congress, and international health ministries to address access to transplantation and cellular therapies. The society collaborates with patient advocacy groups like Susan G. Komen, American Cancer Society Cancer Action Network, and Patient-Centered Outcomes Research Institute to influence regulations from European Medicines Agency and coverage decisions by Centers for Medicare & Medicaid Services.